Abstract
We previously selected a group of hypertension candidate genes by a key word search using the OMIM database of NCBI and validated 525 coding single nucleotide polymorphisms (SNPs) in 179 hypertension candidate genes by DNA sequencing in a Japanese population. In the present study, we examined the association between 61 non-synonymous SNPs and blood pressure variations and hypertension. We used DNA samples taken from 1,880 subjects in the Suita study, a population-based study using randomly selected subjects. Analyses of covariance adjusting for age, body mass index, hyperlipidemia, diabetes, smoking, drinking, and antihypertensive medication revealed that 17 polymorphisms in 16 genes (APOB, CAST, CLCNKB, CTNS, GHR, GYS1, HF1, IKBKAP, KCNJ11, LIPC, LPL, P2RY2, PON2, SLC4A1, TRH, VWF) were significantly associated with blood pressure variations. Multivariate logistic regression analysis with adjustment for the same factors revealed that 11 polymorphisms in 11 genes (CAST, CTLA4, F5, GC, GHR, LIPC, PLA2G7, SLC4A1, SLCI8A1, TRH, VWF) showed significant associations with hypertension. Five polymorphisms in five genes, CAST (calpastatin), LIPC (hepatic lipase), SLC4A1 (band 3 anion transporter), TRH (thyrotropin-releasing hormone), and VWF (von Willebrand factor), were significantly associated with both blood pressure variation and hypertension. Thus, our study suggests that these five genes were susceptibility genes for essential hypertension in this Japanese population.
Similar content being viewed by others
Article PDF
References
Chobanian AV, Bakris GL, Black HR, et al: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560–2572.
Shimamoto T, Iso H, Iida M, et al: Epidemiology of cerebrovascular disease: stroke epidemic in Japan. J Epidemiol 1996; 6: S43–S47.
Omae T, Oita J, Ueda K : The Japanese experience in hemorrhagic stroke. J Hypertens Suppl 1994; 12: S19–S23.
Ueshima H, Zhang XH and Choudhury SR : Epidemiology of hypertension in China and Japan. J Hum Hypertens 2000; 14: 765–769.
Neal B, MacMahon S, Chapman N, Blood Pressure Lowering Treatment Trialists' Collaboration : Effects of ACE inhibitors, calcium antagonists, and other blood-pressure–lowering drugs: results of prospectively designed overviews of randomised trials. Lancet 2000; 356: 1955–1964.
Hansson L, Zanchetti A, Carruthers SG, et al, HOT Study Group: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351: 1755–1762.
Lifton RP, Dluhy RG, Powers M, et al: A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 1992; 355: 262–265.
Shimkets RA, Warnock DG, Bositis CM, et al: Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 1994; 79: 407–414.
Geller DS, Farhi A, Pinkerton N, et al: Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 2000; 289: 119–123.
Wilson FH, Disse-Nicodeme S, Choate KA, et al: Human hypertension caused by mutations in WNK kinases. Science 2001; 293: 1107–1112.
Iwai N, Katsuya T, Ishikawa K, et al: Human prostacyclin synthase gene and hypertension: the Suita Study. Circulation 1999; 100: 2231–2236.
Sugimoto K, Katsuya T, Ohkubo T, et al: Association between angiotensin II type 1 receptor gene polymorphism and essential hypertension: the Ohasama Study. Hypertens Res 2004; 27: 551–556.
Tamaki S, Nakamura Y, Tabara Y, et al: Combined analysis of polymorphisms in angiotensinogen and adducin genes and their effects on hypertension in a Japanese sample: the Shigaraki Study. Hypertens Res 2005; 28: 645–650.
Kokame K, Matsumoto M, Soejima K, et al: Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor–cleaving protease activity. Proc Natl Acad Sci U S A 2002; 99: 11902–11907.
Kamide K, Takiuchi S, Tanaka C, et al: Three novel missense mutations of WNK4, a kinase mutated in inherited hypertension, in Japanese hypertensives: implication of clinical phenotypes. Am J Hypertens 2004; 49: 507–515.
Kamide K, Yang J, Kokubo Y, et al: A novel missense mutation, F826Y, in the mineralocorticoid receptor gene in Japanese hypertensives: its implications for clinical phenotypes. Hypertens Res 2005; 28: 703–709.
Okuda T, Fujioka Y, Kamide K, et al: Verification of 525 coding SNPs in 179 hypertension candidate genes in the Japanese population: identification of 159 SNPs in 93 genes. J Hum Genet 2002; 47: 387–394.
Inamoto N, Katsuya T, Kokubo Y, et al: Association of methylenetetrahydrofolate reductase gene polymorphism with carotid atherosclerosis depending on smoking status in a Japanese general population. Stroke 2003; 34: 1628–1633.
Ishikawa K, Baba S, Katsuya T, et al: T+31C polymorphism of angiotensinogen gene and essential hypertension. Hypertension 2001; 37: 281–285.
Kokubo Y, Kamide K, Inamoto N, et al: Identification of 108 SNPs in TSC, WNK1, and WNK4 and their association with hypertension in a Japanese general population. J Hum Genet 2004; 49: 507–515.
Kokubo Y, Inamoto N, Tomoike H, et al: Association of genetic polymorphisms of sodium-calcium exchanger 1 gene, NCX1, with hypertension in a Japanese general population. Hypertens Res 2004; 27: 697–702.
Tanaka C, Kamide K, Takiuchi S, et al: An alternative fast and convenient genotyping method for the screening of angiotensin converting enzyme gene polymorphisms. Hypertens Res 2003; 26: 301–306.
Matayoshi T, Kamide K, Takiuchi S, et al: The thiazide-sensitive Na+-Cl− cotransporter gene, C1784T, and adrenergic receptor-β3 gene, T727C, may be gene polymorphisms susceptible to the antihypertensive effect of thiazide diuretics. Hypertens Res 2004; 27: 821–833.
Harwood SM, Allen DA, Chesser AM, et al: Calpain is activated in experimental uremia: is calpain a mediator of uremia-induced myocardial injury? Kidney Int 2003; 63: 866–877.
Averna M, De Tullio R, Salamino F, et al: Age-dependent degradation of calpastatin in kidney of hypertensive rats. J Biol Chem 2001; 276: 38426–38432.
Pontremoli S, Melloni E, Sparatore B, et al: Erythrocyte deficiency in calpain inhibitor activity in essential hypertension. Hypertension 1988; 12: 474–478.
Jansen H, Verhoeven AJ, Sijbrands EJ : Hepatic lipase: a pro- or anti-atherogenic protein? J Lipid Res 2002; 43: 1352–1362.
Guerra R, Wang J, Grundy SM, et al: A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc Natl Acad Sci U S A 1997; 94: 4532–4537.
Jarolim P, Shayakul C, Prabakaran D, et al: Autosomal dominant distal renal tubular acidosis is associated in three families with heterozygosity for the R589H mutation in the AE1 (band 3) Cl−/HCO3− exchanger. J Biol Chem 1998; 273: 6380–6388.
Yannoukakos D, Vasseur C, Driancourt C, et al: Human erythrocyte band 3 polymorphism (band 3 Memphis): characterization of the structural modification (Lys 56----Glu) by protein chemistry methods. Blood 1991; 78: 1117–1120.
Hsu L, Morrison M : A new variant of the anion transport protein in human erythrocytes. Biochemistry 1985; 24: 3086–3090.
Garcia SI, Porto PI, Alvarez AL, et al: Central overexpression of the TRH precursor gene induces hypertension in rats: antisense reversal. Hypertension 1997; 30: 759–766.
Garcia SI, Landa MS, Porto PI, et al: Thyrotropin-releasing hormone decreases leptin and mediates the leptin-induced pressor effect. Hypertension 2002; 39: 491–495.
Garcia SI, Porto PI, Dieuzeide G, et al: Thyrotropin-releasing hormone receptor (TRHR) gene is associated with essential hypertension. Hypertension 2001; 38: 683–687.
Garcia SI, Alvarez AL, Porto PI, et al: Antisense inhibition of thyrotropin-releasing hormone reduces arterial blood pressure in spontaneously hypertensive rats. Hypertension 2001; 37: 365–370.
Stehouwer CD, Nauta JJ, Zeldenrust GC, et al: Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non–insulin-dependent diabetes mellitus. Lancet 1992; 340: 319–323.
Spencer CG, Gurney D, Blann AD, et al: Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Hypertension 2002; 40: 61–66.
Goldstein DB : Islands of linkage disequilibrium. Nat Genet 2001; 29: 109–111.
Abecasis GR, Noguchi E, Heinzmann A, et al: Extent and distribution of linkage disequilibrium in three genomic regions. Am J Hum Genet 2001; 68: 191–197.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kokubo, Y., Tomoike, H., Tanaka, C. et al. Association of Sixty-One Non-Synonymous Polymorphisms in Forty-One Hypertension Candidate Genes with Blood Pressure Variation and Hypertension. Hypertens Res 29, 611–619 (2006). https://doi.org/10.1291/hypres.29.611
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1291/hypres.29.611
Keywords
This article is cited by
-
Proteomic and clinical biomarkers for acute mountain sickness in a longitudinal cohort
Communications Biology (2022)
-
Cardiovascular and body weight regulation changes in transgenic mice overexpressing thyrotropin-releasing hormone (TRH)
Journal of Physiology and Biochemistry (2020)
-
Messenger RNA and MicroRNA transcriptomic signatures of cardiometabolic risk factors
BMC Genomics (2017)
-
The E23K and A190A variations of the KCNJ11 gene are associated with early-onset type 2 diabetes and blood pressure in the Chinese population
Molecular and Cellular Biochemistry (2015)
-
Association of the antihypertensive response of iptakalim with KCNJ11 (Kir6.2 gene) polymorphisms in Chinese Han hypertensive patients
Acta Pharmacologica Sinica (2011)
